3 research outputs found

    Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity

    Get PDF
    Tuberculosis, caused by the Mycobacterium tuberculosis (Mtb), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide- containing compounds were synthesized followed by in vitro and in vivo evaluation of their antitubercular potential against Mtb. Compound 8 was found to be the most promising compound, with MIC90 values of 1.10 and 6.62 ÎŒM against active and non- replicating Mtb, respectively. Additionally, we carried out in vivo experiments to confirm the safety and efficacy of compound 8; the compound was found to be orally bioavailable and highly effective leading to the reduction of the number of Mtb to undetected levels in a mouse model of infection. Microarray-based initial studies on the mechanism of action suggest that compound 8 blocks the process of translation. Altogether, these results indicated benzofuroxan derivative 8 to be a promising lead compound for the development of a novel chemical class of antitubercular drugs

    Design, Synthesis, and Characterization of N‑Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity

    Get PDF
    Tuberculosis, caused by Mycobacterium tuberculosis (<i>Mtb</i>), is the infectious disease responsible for the highest number of deaths worldwide. Herein, 22 new N-oxide-containing compounds were synthesized followed by <i>in vitro</i> and <i>in vivo</i> evaluation of their antitubercular potential against <i>Mtb</i>. Compound <b>8</b> was found to be the most promising compound, with MIC<sub>90</sub> values of 1.10 and 6.62 ÎŒM against active and nonreplicating <i>Mtb</i>, respectively. Additionally, we carried out <i>in vivo</i> experiments to confirm the safety and efficacy of compound <b>8</b>; the compound was found to be orally bioavailable and highly effective, leading to a reduction of <i>Mtb</i> to undetectable levels in a mouse model of infection. Microarray-based initial studies on the mechanism of action suggest that compound <b>8</b> blocks translation. Altogether, these results indicate that benzofuroxan derivative <b>8</b> is a promising lead compound for the development of a novel chemical class of antitubercular drugs
    corecore